The size of the European cold plasma market has been calculated at USD 0.82 billion in 2022. It is estimated to grow at a CAGR of 15.6% and be worth USD 1.69 billion by 2027.
The need for cold plasma in the European region is growing due to the increased usage of cold plasma in many industries such as printing, adhesion, coating, and others. Furthermore, certain advantages of cold plasma, including better wettability, reduced chemical use, and reduced water use, are assisting the market's expansion. During food production, processing, and packaging, food decontamination and spoilage minimization are critical issues that must be addressed to ensure food safety and sustainability.
Furthermore, cold plasma technology has offered a new perspective to the concept of food decontamination in ambient conditions, propelling the cold plasma market over the forecast period. Cold plasma's uses in preventing infection and extending the life of personal protective equipment (PPE) will present further growth prospects for the cold plasma market during the forecast period. It is utilized for microbial-free material packaging and meat and poultry packaging. The procedure uses less water, which lowers the cost of wastewater treatment. Furthermore, medical research into its application in the treatment of lung, bladder, skin, and breast cancer has opened up many doors for it. During the forecast period, the use of cold plasma in packaging and medical applications is likely to accelerate the European market.
The need for financial support is a significant constraint in the European cold plasma market. Furthermore, the complex molecular structure is fragmented due to its treatment, making precise structural prediction difficult. Due to pricey equipment and vacuum pumps, small players' initial investments are relatively substantial, making survival difficult. The limited commercialization of cold plasma, on the other hand, may pose a significant challenge to the market's growth in the near future. As a result, it's safe to assume that these factors limited commercialization and low awareness will pose a significant challenge to the market's expansion unless these issues are rectified. In addition, innovations in textile manufacturing are expected to slow the growth of the cold plasma market in the European region.
This research report on the European cold plasma market has been segmented & sub-segmented into the following categories:
In 2020, the European cold plasma market accounted for a promising share in the global market, followed by North America. The presence of a high number of cold plasma companies and expanding R&D efforts in Germany can be linked to Europe's large global market share. With the presence of key international and regional biotechnology businesses, Europe plays a vital role in the global cold plasma market. The key market participants are increasing their capacity to meet the demands of various industries. Cold plasma enhances wound sterilizing, blood coagulation, and cell proliferation in wound healing when used in conjunction with chemotherapy. Its use enables successful medical treatment of cancer and a variety of skin injuries and disorders. It was also discovered that cold plasma was recently employed in Germany in restricted early trials as palliative therapy for head and neck cancer patients. As a result, the growing use of cold plasma in wound healing, cancer treatment, and infectious disease treatment boosts the market's growth. With the help of cold plasma in cancer treatment, many fatal cases might be minimized, resulting in market growth. During the forecast period, Europe is expected to hold a significant share in the global market.
KEY MARKET PLAYERS:
Companies that are a notable role in the Europe Cold Plasma Market profiled in the report are Enercon Industries Corporation, Henniker Plasma, ADTEC Plasma Technology Co. Ltd., Europlasma NV, Neoplas Tools GmbH, P2i Limited, Nordson Corporation, Plasmatreat GmbH, Vetaphone A/S, and Tantec A/S.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org